Many women navigating perimenopause and midlife report changes in their cognitive function, often describing experiences like ‘brain fog,’ difficulty with recall, or a sense of mental sluggishness. These shifts can be a natural part of the aging process and hormonal fluctuations, prompting interest in various strategies to support cognitive well-being.
Inositol, a naturally occurring compound found in many foods, has gained attention for its potential roles in cellular signaling and brain health. This article explores the current scientific understanding of inositol’s connection to cognition and memory, particularly as it relates to the perimenopausal period, drawing on available research to provide an evidence-based perspective.
Understanding Inositol: More Than Just a Sugar
Inositol is a carbocyclic polyol, often referred to as a ‘sugar alcohol,’ but it does not function as a dietary sugar. Instead, it plays a crucial role in various cellular processes, including cell membrane structure and intracellular signaling pathways. Myo-inositol and D-chiro-inositol are two of the most commonly studied forms, with myo-inositol being the most abundant in the brain.
Within the brain, inositol is involved in the signaling of several neurotransmitters, including serotonin and norepinephrine, which are important for mood regulation and cognitive function. Its presence and metabolism are essential for healthy brain function, and alterations in inositol levels can be observed in various neurological conditions.
Inositol and Brain Metabolites: Insights from Research
Magnetic Resonance Spectroscopy (MRS) is a non-invasive technique that allows researchers to measure the concentrations of various brain metabolites, including myo-inositol. Studies using MRS have provided insights into the role of myo-inositol in brain health. For example, research has explored frontal metabolites, including myo-inositol, in healthy older women and those diagnosed with mild cognitive impairment [1].
Another study investigated neurometabolites and antipsychotic response in psychosis, highlighting the broader context of metabolite research in brain function [2]. The interplay of glial cells, which support neurons, and metabolites like myo-inositol in the thalamus has also been a subject of investigation in conditions like Multiple Sclerosis [3]. These studies underscore the importance of inositol in the brain’s metabolic landscape.
Exploring Inositol’s Connection to Cognitive Function
While direct research specifically on inositol’s impact on perimenopausal cognition and memory in humans is still developing, some studies offer related insights. For instance, research in a mouse model of ‘chemobrain’ (cognitive impairment following chemotherapy) demonstrated a pharmacological rescue of cognitive function, indicating potential pathways that could be relevant to cognitive support [4].
The connection between metabolic health and brain function is also relevant. Hyperglycemia and hyperinsulinemia have been shown to affect anterior cingulate cortex myo-inositol levels, which in turn relate to brain network functional connectivity in healthy adults [5]. This suggests a link between metabolic regulation and brain chemistry, which could indirectly influence cognitive processes. Furthermore, research on ApoE2 in aged mice has indicated an influence on insulin signaling in the hippocampus and spatial cognition in a sex-dependent manner, highlighting the complex interplay of genetics, metabolism, and cognitive outcomes [6].
Inositol and Midlife Brain Health: What the Evidence Suggests
The current body of evidence suggests a moderate strength for inositol’s role in general cognitive function, primarily through its involvement in brain metabolism and neurotransmitter signaling. While direct, large-scale human trials specifically addressing inositol’s impact on perimenopausal cognitive changes are not yet abundant, the existing research points to its foundational role in brain health.
It’s important to recognize that cognitive changes during midlife are multifactorial, influenced by hormonal shifts, lifestyle, genetics, and overall health. Inositol’s potential contribution to supporting cognitive well-being would likely be as part of a broader approach to healthy aging, rather than a standalone solution.
References
- Frontal Metabolites and Alzheimer’s Disease Biomarkers in Healthy Older Women and Women Diagnosed with Mild Cognitive Impairment. Journal of Alzheimer’s disease : JAD, 2022
- Neurometabolites and Antipsychotic Response in Psychosis: A Mega-Analysis. JAMA psychiatry, 2026
- Decoding Thalamic Glial Interplay in Multiple Sclerosis Through Proton Magnetic Resonance Spectroscopy and Positron Emission Tomography. International journal of molecular sciences, 2025
- Pharmacological rescue of cognitive function in a mouse model of chemobrain. Molecular neurodegeneration, 2021
- Hyperglycemia and hyperinsulinemia effects on anterior cingulate cortex myoinositol-relation to brain network functional connectivity in healthy adults. Journal of neurophysiology, 2022
- ApoE2 affects insulin signaling in the hippocampus and spatial cognition of aged mice in a sex-dependent manner. Cell communication and signaling : CCS, 2025
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
